Kindred Biosciences, Inc. logo
Kindred Biosciences, Inc. KIN
$ 9.25 0.11%

Kindred Biosciences, Inc. Financial Statements 2011-2024 | KIN

Annual Financial Statements Kindred Biosciences, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

196 M 351 M 305 M 222 M 128 M 65.3 M 119 M 61.6 M - -

Shares

39.3 M 38.7 M 31 M 25.1 M 19.9 M 19.8 M 18.8 M 3.73 M - -

Net Income

-21.8 M -61.4 M -49.7 M -30.9 M -22.5 M -27.1 M -27.1 M -1.83 M -120 K -

Revenue

42.2 M 4.26 M 1.97 M - - - - - - -

EBITDA

-11 M -60 M -50.5 M -31.2 M -22 M -27.1 M -27.2 M -1.83 M -120 K -

Operating Expenses

53.3 M 66.2 M 52.9 M 31.7 M 22.2 M 27.3 M 27.2 M - - -

General and Administrative Expenses

22 M 37.9 M 22.1 M 11.9 M 6.84 M 6.86 M 8.54 M 438 K 45 K -

All numbers in USD currency